Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Prepulsid labeling revised in Canada

March 6, 2000

ISIS-14803 begins phase I/II evaluation as HCV treatment

March 2, 2000

Hepatitis C vaccine candidate identified by Epimmune

March 2, 2000

Searle identifies novel series of LTA4 hydrolase inhibitors, some with good oral activity

Feb. 29, 2000

Hepatitis C product candidate enters phase I testing in U.K.

Feb. 29, 2000

Millennium commences phase II clinical trial of LDP-02 for treatment of Crohn's disease

Feb. 28, 2000

Altus receives funding for GI lipase enzyme therapy

Feb. 24, 2000

Telomerase gene therapy may offer potential liver cirrhosis therapy

Feb. 24, 2000

CPMP issues positive opinion regarding PEG-Intron MAA

Feb. 23, 2000

BioMedicines files IND for interferon omega

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...